Saturday 17 October 2026 Export FATE’s income statement to Excel — free account

Fate Therapeutics, Inc.

Fate Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 million, down 51.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.18%, EPS grew 13.8% and free cash flow grew 8.96%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

1.79 0.14 −7.25%

Follow FATE

Alert me

Market cap: $230.7M
P/E: 0.0×
Fwd P/E: −1.8×
Dividend yield: —
F-score: 3/9
Altman Z: −6.97
Beneish M: −4.02
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	50.08	22.81	17.52	21.01
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(13.87)	(4.67)	(4.99)	(6.15)
P/B ratio Full definition →	2.12	0.80	0.56	0.64
Price to Tangible BV Full definition →	2.12	0.80	0.56	0.64
EV/Sales Full definition →	30.00	(1.17)	(9.61)	(5.90)
EV/EBITDA Full definition →	0.00	0.06	0.46	0.26
EV/Operating CF Full definition →	(1.91)	0.07	0.60	0.38
EV/FCF Full definition →	(1.85)	0.07	0.57	0.37
Quick Ratio Full definition →	4.74	5.72	5.67	7.69
Current Ratio Full definition →	4.85	5.85	5.79	7.87
Net Debt/EBITDA Full definition →	5.28	5.67	6.26	6.67
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.02	0.02	0.02	0.02
Operating CF/Net income Full definition →	0.78	0.99	0.72	0.76
Capex/Depreciation Full definition →	(0.04)	(0.11)	(0.44)	(0.91)
Research and Development Expense of Revenue Full definition →	1,171.33%	1,901.69%	1,857.20%	1,484.09%
Selling, General and Administrative Expense of Revenue Full definition →	424.06%	738.72%	779.04%	611.03%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	168.97%	302.46%	403.80%	279.21%
Graham Net Nets Full definition →	0.16	0.52	0.83	0.74
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(38.89%)	(90.83%)	(117.35%)	(104.76%)
Free Cash Flow Yield Full definition →	(32.43%)	(74.79%)	(95.93%)	(76.90%)
Revenue per Share Full definition →	0.02	0.01	0.01	0.01
Operating CF per Share Full definition →	(0.19)	(0.26)	(0.20)	(0.20)
Capex per Share Full definition →	0.00	0.00	(0.01)	(0.02)
Free Cash Flow per Share Full definition →	(0.20)	(0.26)	(0.20)	(0.22)
Cash per Share Full definition →	1.28	1.46	1.71	1.81
Shareholders Equity per Share Full definition →	1.27	1.50	1.74	1.97
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.27	1.50	1.74	1.97
Free Cash Flow Full definition →	(23.51)	(31.06)	(24.27)	(26.57)
Working Capital Full definition →	125.36	148.84	172.63	193.14
Capital Expenditures Full definition →	(0.08)	(0.24)	(0.95)	(2.20)
Net Current Asset Value Full definition →	51.29	74.32	96.95	111.65
EV/EBIT Full definition →	0.00	0.05	0.43	0.24
Capex to Sales Full definition →	0.04	0.18	0.70	1.26
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	1.05	1.56	2.23	2.40
Average Payables Full definition →	3.65	3.73	6.01	4.93
Average Assets Full definition →	315.87	341.79	379.82	419.32
Average Common Equity Full definition →	207.40	234.06	262.95	298.19

Show all line items

Columns are period end dates

Stockrow Weekly